Proteomics International

Proteomics International is a specialist technology-driven life science company based in Perth, Western Australia. The Company's technology platform has been successfully applied to biomarker discovery in multiple project areas, in particular diabetic kidney disease, and the sensitivity and specificity of the approach is opening the door to personalised medicine.

Proteomics International operates in three synergistic business units: Diagnostics (biomarker discovery), Therapeutics (drug discovery of peptide medicines) and Analytics (biosimilars CRO). The Company, established in 2001, provides services to groups throughout the Indo-Asian region, and was the world's first provider of proteomics services to be accredited to ISO/IEC 17025 laboratory standard.

View Site Show On Map